1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3- phosphocholine

Metabolite details

Identifier

GLPAGCOJQYNMCC-NEEAVLKMSA-N

InChI Key

GLPAGCOJQYNMCC-NEEAVLKMSA-N

IUPAC name

(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3- phosphocholine

INN name

—

Synonym

GPCho 18:0/22:5(4Z,7Z,10Z,13Z,16Z)

ChEBI

CHEBI:73865

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Healthy_Control_vs_Osteoarticular_Tuberculosis
• Knockdown_vs_Control
• Knockdown_vs_Control
• BSA_Control_vs_AA